CORRESP 3 filename3.txt [LOGO] SandersBaker PC ROBERT R. SANDERS MAILING ADDRESS: ART BAKER ONE MAXOR PLAZA MITCH D. CARTHEL 320 S. POLK STREET, SUITE 700 ROGER S. COX AMARILLO, TEXAS 79101 RUSS DEVORE* P.O. BOX 2667 EDWARD L. MORRIS AMARILLO, TEXAS 79105-2667 CHRIS WRIGHT (806) 372-2020 JUSTIN E. MYERS FAX (806) 372-3725 JOHN B. ATKINS sender's email: emorris@sandersbaker.com *ADMITTED IN TEXAS, NEW MEXICO, OKLAHOMA & COLORADO May 26, 2006 US Securities and Exchange Commission Division of Corporation Finance Attn: Jeffrey Riedler, Assistant Director 100 F Street NE Washington, DC 20549-6010 Re: Your letter of May 25, 2006, subject: Amarillo Biosciences, Inc. Preliminary Proxy Statement on Schedule 14A filed April 25, 2006, revised May 19, 2006 File No. 333-04413 Dear Mr. Riedler: As requested by your letter dated May 25, 2006, to Amarillo Biosciences, Inc. (the "Company"), subject as above, I am pleased to respond on behalf of the Company. I have numbered my responses according to the numbering system you used in your letter, for ease of reference. 1. We have again instructed the Edgar filing service to submit the preliminary proxy materials under File No. 0-20792, which is the correct 1934 Act filing number. 2. We have made the requested revision. 3. We have made the requested revisions. 4. We have rewritten the "Certain Transactions" portion of the Proxy Statement to include the current status of all of the Company's material relationships with HBL. 5. We have made the requested revision. 6. We have made the requested revision. Mr. Jeffrey Riedler May 18, 2006 Page 2 of 2 If you require any additional information or additional changes are required, please contact the undersigned at the number shown above. Very truly yours, SANDERSBAKER PC /s/ Edward L. Morris Edward L. Morris ELM/mh c Amarillo Biosciences, Inc. Joseph M. Cummins, President (806) 376-9301 - Fax